安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Janssen - Home | Global Trial Finder
What You Can Expect To Happen In A Clinical Trial Clinical trials are rarely the same They can last from weeks to years, study different doses of a medication, or even compare multiple medications at once While the details change, all trials are structured in a similar way Typically, there are four main parts of a trial, with each part serving a different purpose
- Janssen | 2022 Transparency Report
Through the 2022 Janssen U S Transparency Report, we continue our legacy of contributing insights, data and real-world evidence to help inform and advance policy solutions to create a more sustainable, equitable and innovative healthcare system
- Johnson Johnson submits application to U. S. FDA seeking . . . - Janssen
Janssen-Cilag International NV, a Johnson Johnson company, previously announced the submission of applications to the European Medicines Agency (EMA) seeking to expand the Marketing Authorization Application for TREMFYA® to include the treatment of adult patients with moderately to severely active ulcerative colitis and moderately to
- A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of . . .
The purpose of this study is to assess how bleximenib and Venetoclax (VEN)+ Azacitidine (AZA) works as compared to placebo and VEN+AZA alone for the treatment of participants with Acute Myeloid Leukemia (AML)
- A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting . . . - Janssen
A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer Last Updated May 14, 2025
- Smart Form - connect. janssen. com
Report a potential Medical Concern Medical Inquiries Example of potential issues may include (but are not limited to): Signs, such as skin rash, weight loss Symptoms, such as headache, dizziness, nausea Diseases, such as hypertension, diabetes, infection Abnormal Test or Laboratory Findings, such as elevated cholesterol, low potassium Any other untoward condition health consequence that
- A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to . . .
The main purpose of this study is to assess how well JNJ-77242113 works when compared to placebo and ustekinumab in participants with moderate to severe plaque psoriasis
- A Study of Amivantamab Alone or in Addition to Other . . . - Janssen
The purpose of this study is to determine safety and preliminary efficacy of amivantamab monotherapy, amivantamab in addition to pembrolizumab, amivantamab in addition to paclitaxel and amivantamab in addition to pembrolizumab and carboplatin in participants with recurrent metastatic head and neck cancer The study will also confirm the recommended Phase 2 combination dose (RP2CD) for
|
|
|